KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Invested Capital (2016 - 2025)

Historic Invested Capital for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $7.8 billion.

  • Quest Diagnostics' Invested Capital fell 4042.93% to $7.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 billion, marking a year-over-year decrease of 4042.93%. This contributed to the annual value of $13.0 billion for FY2024, which is 1786.52% up from last year.
  • Latest data reveals that Quest Diagnostics reported Invested Capital of $7.8 billion as of Q3 2025, which was down 4042.93% from $7.8 billion recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Invested Capital peaked at $13.1 billion during Q3 2024, and registered a low of $5.9 billion during Q2 2021.
  • Its 5-year average for Invested Capital is $8.0 billion, with a median of $7.2 billion in 2025.
  • Its Invested Capital has fluctuated over the past 5 years, first crashed by 4317.14% in 2021, then soared by 9346.83% in 2024.
  • Quest Diagnostics' Invested Capital (Quarter) stood at $10.5 billion in 2021, then decreased by 5.57% to $9.9 billion in 2022, then rose by 11.55% to $11.1 billion in 2023, then grew by 17.87% to $13.0 billion in 2024, then tumbled by 40.15% to $7.8 billion in 2025.
  • Its last three reported values are $7.8 billion in Q3 2025, $7.8 billion for Q2 2025, and $7.2 billion during Q1 2025.